Voyager Therapeutics Inc (VYGR)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

75 SIDNEY STREET CAMBRIDGE, MA 02139

Voyager Therapeutics, Inc. operates as a clinical-stage gene therapy company. The Company focuses on developing life-changing treatments for patients suffering from severe diseases of the central nervous system. Voyager Therapeutics develops gene therapies for fatal and debilitating diseases.

Data as of 2021-05-08 11:42:35 -0400
Market Cap162.608 Million Shares Outstanding37.728 Million Avg 30-day Volume784.512 Thousand
P/E Ratio4.4258 Dividend Yield EPS0.984
Price/Sales0.9502 Debt to Equity1.7 EBITDA31.201 Million
Price to Book Value1.05 Forward PE-1.62 Enterprise Value-18.53 Million
Total Cash181.138 Million Current Debt26.766 Million Gross Profit171.128 Million
BETA1.51241 52-week High/Low14.62 / 4.21 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from VYGR instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 1 0.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 101 110 -8.18% 24 (1.44%) 27 (1.68%) -11.11%
13F shares: 27.304 Million 27.728 Million -1.53% 8.728 Million 7.753 Million 12.57%
% Ownership 72.8766 74.0079 -1.53% 23.2958 20.6944 12.57%
New Positions: 10 14 -28.57% 4 2 100.0%
Increased Positions 32 24 33.33% 11 7 57.14%
Closed Positions 18 17 5.88% 7 9 -22.22%
Reduced Positions 34 40 -15.0% 8 14 -42.86%
Total Calls 23.531 Thousand 31.311 Thousand -24.85% 17.7 Thousand 11.2 Thousand 58.04%
Total Puts 235.1 Thousand 0 157.9 Thousand
PUT/CALL Ratio 9.99 0.0 8.92 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding VYGR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VYGR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

3.3 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HESSLEIN ROBERT W. SENIOR VP & GENERAL COUNSEL

  • Officer
110,056 2021-04-05 4

DORVAL ALLISON CHIEF FINANCIAL OFFICER

  • Officer
109,894 2021-03-19 4

TURENNE ANDRE PRESIDENT & CEO

  • Officer
  • Director
322,375 2021-03-19 4

KHWAJA OMAR SEE REMARKS

  • Officer
124,025 2021-03-19 4

VITALE NANCY

  • Director
0 2020-09-15 2

PAUL STEVEN M

  • Director
0 2020-06-04 1

GERAGHTY JAMES A

  • Director
0 2020-06-04 1

HYMAN STEVEN

  • Director
0 2020-06-04 1

HIGGINS MICHAEL J

  • Director
0 2020-06-04 1

LEVIN MARK J

  • Director
0 2020-06-04 1

DIXON WENDY L

  • Director
0 2020-06-04 1

PIERCE GLENN

  • Director
0 2020-06-04 1

OTTMER MATTHEW P. CHIEF OPERATING OFFICER

  • Officer
26,276 2020-01-21 0

KARSEN PERRY A

  • Director
0 2019-06-13 0

NEUROCRINE BIOSCIENCES INC

  • 10% Owner
0 2019-03-12 0

SAH DINAH PH.D. CHIEF SCIENTIFIC OFFICER

  • Officer
163,688 2019-01-11 0

THIRD ROCK VENTURES III, L.P.

THIRD ROCK VENTURES GP III, L.P.

TRV GP III, LLC

STARR KEVIN P

TEPPER ROBERT I

  • 10% Owner
6,464,577 2018-09-19 0

RAVINA BERNARD CHIEF MEDICAL OFFICER

  • Officer
0 2018-04-10 0

HENDERSON JANE SR. V.P. & CFO, CORP. DEV.

  • Officer
0 2018-03-22 0

GOATER JEFF CHIEF FINANCIAL OFFICER

  • Officer
0 2016-02-01 0

HADLEY HARBOR MASTER INVESTORS (CAYMAN) L.P.

  • 10% Owner
No longer subject to file 2015-11-16 0

SANOFI

  • FORMER 10% OWNER
No longer subject to file 2015-11-16 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HESSLEIN ROBERT W. - Officer SENIOR VP & GENERAL COUNSEL

2021-04-07 17:44:52 -0400 2021-04-05 S 3,292 $4.95 a 110,056 direct -0.2096 -1.0482 0.4193 5 -3.5639 4

DORVAL ALLISON - Officer CHIEF FINANCIAL OFFICER

2021-03-23 16:10:28 -0400 2021-03-19 A 30,000 a 109,894 direct 6.0738 2.1692 -4.9892 18.0043 23 -7.1584 30

HESSLEIN ROBERT W. - Officer SENIOR VP & GENERAL COUNSEL

2021-03-23 16:11:35 -0400 2021-03-19 A 30,000 a 113,348 direct 6.0738 2.1692 -4.9892 18.0043 23 -7.1584 30

TURENNE ANDRE - Director - Officer PRESIDENT & CEO

2021-03-23 16:10:57 -0400 2021-03-19 A 80,000 a 322,375 direct 6.0738 2.1692 -4.9892 18.0043 23 -7.1584 30

KHWAJA OMAR - Officer SEE REMARKS

2021-03-23 16:12:13 -0400 2021-03-19 A 35,000 a 124,025 direct 6.0738 2.1692 -4.9892 18.0043 23 -7.1584 30

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
VOYAGER THERAPEUTICS INC VYGR 2021-05-11 22:15:03 UTC -0.9253 0.9753 150000
VOYAGER THERAPEUTICS INC VYGR 2021-05-11 21:45:03 UTC -0.9253 0.9753 150000
VOYAGER THERAPEUTICS INC VYGR 2021-05-11 21:15:03 UTC -0.9253 0.9753 150000
VOYAGER THERAPEUTICS INC VYGR 2021-05-11 20:45:03 UTC -0.9253 0.9753 150000
VOYAGER THERAPEUTICS INC VYGR 2021-05-11 20:15:03 UTC -0.9253 0.9753 150000
VOYAGER THERAPEUTICS INC VYGR 2021-05-11 19:45:03 UTC -0.9253 0.9753 150000
VOYAGER THERAPEUTICS INC VYGR 2021-05-11 19:15:02 UTC -0.9253 0.9753 150000
VOYAGER THERAPEUTICS INC VYGR 2021-05-11 18:45:02 UTC -0.6681 0.7181 150000
VOYAGER THERAPEUTICS INC VYGR 2021-05-11 18:15:03 UTC -0.6681 0.7181 150000
VOYAGER THERAPEUTICS INC VYGR 2021-05-11 17:45:03 UTC -0.6681 0.7181 150000
VOYAGER THERAPEUTICS INC VYGR 2021-05-11 17:15:04 UTC -0.6681 0.7181 150000
VOYAGER THERAPEUTICS INC VYGR 2021-05-11 16:45:04 UTC -0.6736 0.7236 150000
VOYAGER THERAPEUTICS INC VYGR 2021-05-11 16:15:04 UTC -0.6736 0.7236 150000
VOYAGER THERAPEUTICS INC VYGR 2021-05-11 15:45:03 UTC -0.6736 0.7236 150000
VOYAGER THERAPEUTICS INC VYGR 2021-05-11 15:15:03 UTC -0.6736 0.7236 150000
VOYAGER THERAPEUTICS INC VYGR 2021-05-11 14:45:03 UTC -0.6114 0.6614 150000
VOYAGER THERAPEUTICS INC VYGR 2021-05-11 14:15:03 UTC -0.6114 0.6614 150000
VOYAGER THERAPEUTICS INC VYGR 2021-05-11 13:45:04 UTC -0.6114 0.6614 150000
VOYAGER THERAPEUTICS INC VYGR 2021-05-11 13:15:04 UTC -0.6114 0.6614 150000
VOYAGER THERAPEUTICS INC VYGR 2021-05-11 12:45:03 UTC -0.6114 0.6614 100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund VYGR -4.0 shares, $-36.6 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund VYGR -10.0 shares, $-91.5 2020-03-31 N-PORT

Elevate your investments